IGC Pharma, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a IGC research report →
About the company
IGC Pharma, Inc. operates as a pharmaceutical firm, currently in the clinical development phase, dedicated to pioneering novel treatments for Alzheimer's, a debilitating condition. The company's pipeline includes two experimental drug candidates aimed at this disease: IGC-AD1, which is presently undergoing a Phase 2 clinical study for addressing agitation associated with Alzheimer's-related dementia, and TGR-63, which is still in its preclinical stage.
- CEO
- Ram Mukunda
- IPO
- 2006
- Employees
- 67
- HQ
- Potomac, MD, US
Price Chart
- Market Cap
- $28.12M
- P/E
- -3.89
- P/S
- 23.71
- P/B
- 4.36
- EV/EBITDA
- -4.68
- Div Yield
- 0.00%
- Gross Margin
- 29.68%
- Op Margin
- -860.29%
- Net Margin
- -552.11%
- ROE
- -94.51%
- ROIC
- -144.79%
- Revenue
- $1.19M · -6.69%
- Net Income
- $-6,548,000 · 8.05%
- EPS
- $-0.07 · 22.34%
- Op Income
- $-10,203,000
- FCF YoY
- -15.73%
- 52W High
- $0.50
- 52W Low
- $0.24
- 50D MA
- $0.29
- 200D MA
- $0.32
- Beta
- 0.45
- Avg Volume
- 1.27M
Get TickerSpark's AI analysis on IGC
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 30, 26 | Mukunda Ram | other | 2,226,475 |
| Jun 30, 26 | GRIMALDI CLAUDIA | other | 2,048,378 |
| Apr 1, 26 | PRINS RICHARD K | other | 70,000 |
| Apr 1, 26 | PRINS RICHARD K | other | 100,000 |
| Apr 1, 26 | PRINS RICHARD K | other | 70,000 |
| Apr 1, 26 | PRINS RICHARD K | other | 100,000 |
| Apr 1, 26 | Mukunda Ram | other | 323,077 |
| Apr 1, 26 | Mukunda Ram | other | 333,333 |
| Apr 1, 26 | Mukunda Ram | other | 33,332 |
| Apr 1, 26 | Mukunda Ram | other | 16,667 |
Our IGC coverage
Recent articles, reports, and earnings notes.
No research on IGC yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate IGC report →Similar companies
Peers in the same neighborhood.